USP suspected herbal hepatotoxicity: Quality of causality assessment is more important than quantity of counted cases, not vice versa

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 3, 2012, Pages 336-338

  Teschke, Rolf ^a   Schmidt Taenzer, Wolfgang ^a   Wolff, Albrecht ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; GREEN TEA EXTRACT;

ALGORITHM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HERBAL MEDICINE; HUMAN; LETTER; LIVER INJURY; LIVER TOXICITY; MEDICAL LITERATURE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

EID: 84858192744     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3209     Document Type: Letter

References (16)

1. Mahady G, Dog TL, Sarma ND, Griffiths J, Giancaspro GI. Response to Teschke et al. Pharmacoepidemiol Drug Saf 2012; 21: 339-340.
2. Teschke R, Schmidt-Taenzer W, Wolff A, Gail M, Tieraona LD, Nandakumara DS, James G, Gabriel IG. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: Is the liver unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol Drug Saf 2011; 20: 567-582.
3. Teschke R. Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: A critical review. Menopause 2010; 17: 426-440.
4. Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH. Herb induced liver injury presumably caused by black cohosh: A survey of initially purported cases and herbal quality specifications. Ann Hepatol 2011; 11: 249-259.
5. Teschke R, Schwarzenboeck A. Suspected hepatotoxicity by Cimicifuga racemosa rhizoma (black cohosh, root): Critical analysis and structured causality assessment. Phytomedicine 2009; 16: 72-84.
6. Teschke R, Bahre R, Fuchs J, Wolff A. Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases. Menopause 2009; 16: 956-965.
7. Teschke R, Bahre R, Genthner A, Fuchs J, Schmidt-Taenzer W, Wolff W. Suspected black cohosh hepatotoxicity - Challenges and pitfalls of causality assessment. Maturitas 2009; 63: 302-314.
8. Teschke R, Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: Are they appropriate? Regul Tox Pharmacol 2011; 59: 1-7.
9. Liss G, Lewis JH. Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol 2009; 5: 843-860.
10. Mahady GB, Low Dog T, Barrett ML, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro GI, Sarma DN. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15: 628-638.
11. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Low Dog T. Safety of green tea extract: a systematic review by the US Pharmacopeia. Drug Saf 2008; 31: 469-484.
12. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330.
13. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66: 758-766.
14. Naser B, Schnitker J, Minkin MJ, Garcia de Arriba S, Noltke KU, Osmers R. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause 2011; 18: 366-375.
15. European Medicines Agency. (EMA): Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). Issued May 8, 2007. Available at: Accessed September 30, 2011.
16. Teschke R, Bahre R, Genthner A, Fuchs J, Schmidt-Taenzer W, Wolff A. Suspected black cohosh hepatotoxicity - Causality assessment versus safety signal. Quality versus quantity. Maturitas 2009; 64: 141-142.